EMCDDA Home
  • EN
Search

Table TDI-104. New clients entering inpatient treatment by primary drug and age, 2010 or most recent year available

Part (iii) New stimulants (other than cocaine) inpatient clients by country and age

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium101021000404
Bulgaria01000000101
Czech Republic211721415075191335936599
Denmark00420001707
Germany01228271380391091
Estonia:::::::::::
Ireland0122212010010
Greece00010010202
Spain:::::::::::
France:::::::::::
Italy:::::::::::
Cyprus00000000000
Latvia:::::::::::
Lithuania:::::::::::
Luxembourg:::::::::::
Hungary0156011014014
Malta:::::::::::
Netherlands1111815830157057
Austria01403010909
Poland22152524811076076
Portugal:::::::::::
Romania00420000606
Slovenia:::::::::::
Slovakia1345025114101260126
Finland0066431020020
Sweden0124927182012611990199
Uk30129762532032
Croatia00120010404
Turkey0560121015015
Norway:::::::::::
Total6212418300151683774126661272
 

Notes:

: Indicates no data are available.

(1) In Belgium if the exact primary drug is not known, the generic category is recorded. In 2010 there were 96 Opiates, 1 Cocaine and 1 Hypnotics and Sedatives clients with the primary exact drug unknown. Of which 3 and 1 were new clients for respectively Opiates and Cocaine.

(2) Data are from 2009. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(3) Data are from 1st of April 2009 to 31st March 2010.

See also 'tdi-10-p12345678-07-Age distribution summary.xls' 'partv',' partvi' and 'General notes for interpreting data' on the Explanatory notes and help page.

Source:

2011 REITOX National Reports - Table TDI Inpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Monday, 09 July 2012